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Abstract
This paper studies the dynamics of a network-based SIRS epidemic model with
vaccination and a nonmonotone incidence rate. This type of nonlinear incidence can
be used to describe the psychological or inhibitory effect from the behavioral change of
the susceptible individuals when the number of infective individuals on heterogeneous
networks is getting larger. Using the analytical method, epidemic threshold R0 is
obtained. When R0 is less than one, we prove the disease-free equilibrium is globally
asymptotically stable and the disease dies out, while R0 is greater than one, there exists
a unique endemic equilibrium. By constructing a suitable Lyapunov function, we also
prove the endemic equilibrium is globally asymptotically stable if the inhibitory factor
α is sufficiently large. Numerical experiments are also given to support the theoretical
results. It is shown both theoretically and numerically a larger α can accelerate the
extinction of the disease and reduce the level of disease.
Keywords: SIRS Epidemic model; Complex networks; Global stability; Nonmonotone
incidence.
1 Introduction
Mathematical models which describe the dynamics of infectious diseases have played a crucial
role in the disease control in epidemiological aspect. In the traditional epidemiology, it is
commonly assumed that individuals mix uniformly and all hosts have identical rates of
disease-causing contacts. This over-simplified assumption makes the analysis tractable but
not realistic [1]. Virtually, the interpersonal contact underlying disease transmission can be
thought of expanding a complex network, where relations (edges) join individuals (nodes)
who interact with each other [10,14]. Therefore, the disease transmission should be modeled
over complex networks. Related studies indicated that networks structures have profound
impacts on the spreading dynamics [13, 16, 18, 26].
One of the pioneer works in this area was done by Pastor-Satorras and Vespignani
[14, 15], where they first succeeded in studying susceptible-infectious-susceptible (SIS) epi-
demic model on scale-free networks by large-scale simulations. The most striking result
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2is that they found the absence of the epidemic threshold in these networks. That is, the
threshold approaches zero in the limit of a large number of edges and nodes, and even a quite
small infectious rate can produce a major epidemic outbreak, for which the rigorous proof
was given by Wang and Dai [17] by a monotone iterative technique. Moreno et al. [11] stud-
ied susceptible-infectious-recovered (SIR) epidemic model on scale-free complex population
networks. They show that the large connectivity fluctuations usually found in these networks
strengthen considerably the incidence of epidemic outbreaks. These outstanding results have
inspired a great number of related works (see Refs. [4,7–9,20,25] and the references therein).
It is well-known that the spread of many human diseases can be prevented or reduced by
vaccination of the susceptible individuals. Chen and Sun [3] firstly succeeded in studying op-
timal control of an susceptible-infectious-recovered-susceptible (SIRS) epidemic model with
vaccination on heterogeneous networks. They showed that if the percentage of vaccination of
the susceptible is smaller than the recovered rate, the diseases may persist on heterogeneous
networks.
We shall emphasize that the incidence rate plays an important role in guaranteeing
that the model can give a reasonable approximative description for the disease dynamics.
However, in most existing epidemic models on complex networks, the incidence rate is usually
assumed to be bilinear function based on the mass action law for infection. In fact, there are
several reasons for using nonlinear incidence rates, even nonmonotone incidence function [12,
21–24]. In practical situations, the number of effective contacts between infective individuals
and susceptible individuals usually decreases at high infective levels due to the quarantine of
infective individuals or due to the protection measures by the susceptible individuals. Very
recently, for modelling such a psychological behavior on complex networks, Li [6] studied the
dynamics of a network-based SIS epidemic model with nonmonotone incidence rate,

dSk(t)
dt
= −λkSk(t)g(Θ) + Ik(t),
dIk(t)
dt
= λkSk(t)g(Θ)− Ik(t), k = 1, 2, · · · , n,
(1.1)
where λ > 0 is the transmission rate when susceptible individuals contact with infectious.
Sk(t) and Ik(t) denote the relative densities of susceptible and infectious with degree k
at time t on the complex networks with maximum degree n. The connectivity of nodes
on the network is assumed to be uncorrelated, thus, we have Θ(t) = 1
〈k〉
∑n
k=1 kP (k)Ik(t)
with 〈k〉 = ∑nk=1 kP (k) is the average degree of the network and P (i) is the connectivity
distribution.
The function g(Θ) is introduced in SIS model (1.1) to reflect the psychological behavior
mentioned above, which leads to nonlinear incidence rate defined by
λkSk(t)g(Θ) := λkSk(t)
Θ
1 + αΘ2
, (1.2)
where α ≥ 0 is a parameter.
When α = 0, then the nonlinear incidence rate (1.2) becomes the bilinear one. Hence, the
SIS model with (1.2) can be seen a generalization of the existing SIS model. Meanwhile, if α
is large enough (e.g., α > 2), the function g becomes a nonmonotone function. The biological
meaning is that at high infective risk (i.e., when Θ is sufficiently large), the incidence rate
may decrease as Θ increases because individuals become more careful and tend to reduce
3their contacts with other ones. In this sense, we call the parameter α inhibitory factor from
the behavioral change of the susceptible individuals.
Inspired by the works of [3] and [6], in this paper we propose the following SIRS epidemic
model with vaccination and the nonmonotone incidence rate as follows,

dSk(t)
dt
= −λkSk(t) Θ(t)
1 + αΘ2(t)
+ δRk(t)− µSk(t),
dIk(t)
dt
= λkSk(t)
Θ(t)
1 + αΘ2(t)
− γIk(t),
dRk(t)
dt
= γIk(t)− δRk(t) + µSk(t), k = 1, 2, · · · , n.
(1.3)
where Sk(t), Ik(t), Rk(t) denote the relative densities of susceptible nodes, infectious nodes
and recovered nodes with degree k respectively. δ > 0 represents the rate of immunization-
lost for recovered nodes; γ > 0 represents the recovery rate of infected nodes; µ > 0 represents
the vaccination percentage for the susceptible nodes.
Among the existing epidemic models on complex networks, there has far been relatively
little research into network epidemic models with nonlinear incidence rate. In [6], the author
successfully proposed the SIS model with nonmonotone incidence rate and obtained the
epidemic threshold. It was proved that if the transmission rate is below the threshold, the
disease-free equilibrium is globally asymptotically stable, otherwise the endemic equilibrium
is permanent. In our recent paper [19], the global stability and attractivity of the endemic
equilibrium of system (1.1) is rigourously proved. When α = 0, the proposed model (1.3)
can be simplified to the model proposed by Chen and Sun [3]. In this paper, the global
stability of disease-free equilibrium as well as the endemic equilibrium is rigourously proved
without additional assumptions on the constants, which improves the existing results.
The remainder of this paper is organized as follows. In Section 2, we show that the
solutions of system (1.3) are positive and the epidemic threshold is obtained. In Section 3, we
study the global stability of the disease-free equilibrium as well as the endemic equilibrium.
In Section 4, numerical experiments are given to illustrate the theoretical results. Finally,
conclusions are drawn in Section 5.
2 Positivity of solutions and the epidemic threshold
From a practical perspective, the initial conditions for system (1.3) satisfy
Ik(0) ≥ 0, Rk(0) ≥ 0, Sk(0) = 1− Ik(0)−Rk(0) > 0, k = 1, 2, . . . , n, Θ(0) > 0. (2.1)
Note that d
dt
(Sk(t) + Ik(t) +Rk(t)) = 0 and Sk(t) + Ik(t) +Rk(t) = 1 for all t ≥ 0 and for all
k = 1, 2, . . . , n. So the system (1.3) becomes the following form:

dSk(t)
dt
= −λkSk(t) Θ(t)
1 + αΘ2(t)
+ δ(1− Sk(t)− Ik(t))− µSk(t),
dIk(t)
dt
= λkSk(t)
Θ(t)
1 + αΘ2(t)
− γIk(t), k = 1, 2, · · · , n.
(2.2)
As system (2.2) is equivalent to the system (1.3), from now on we only consider the
dynamics of (2.2).
First we establish the positivity of solutions of system (2.2) in the following lemma.
4Lemma 2.1. Let (S1, I1, . . . , Sn, In) be the solution of SIRS system (2.2) with initial condi-
tions (2.1). Then for k = 1, 2, . . . , n, we have 0 < Sk(t) < 1, 0 < Ik(t) < 1, and 0 < Θ(t) < 1
for all t > 0.
The proof is shown in Appendix A.
Now we are going to compute all biologically feasible equilibria (Sk, Ik) admitted by
system (2.2).
First, it is easy to see the disease-free equilibrium of (2.2) is E0 = ( δ
δ+µ
, 0, . . . , δ
δ+µ
, 0).
In order to calculate the epidemic equilibrium E∗(S∗1 , I
∗
1 , . . . , S
∗
n, I
∗
n). Let S
′
k(t) = 0 and
I ′k(t) = 0. It follows from (2.2) that

Sk =
γδ + αδγΘ2
γ(δ + µ) + λ(δ + γ)kΘ+ αγ(δ + µ)Θ2
,
Ik =
λδkΘ
γ(δ + µ) + λ(δ + γ)kΘ+ αγ(δ + µ)Θ2
, k = 1, 2, . . . , n.
(2.3)
where Θ = 1
〈k〉
n∑
i=1
iP (i)Ii. From (2.3), we obtain the self-consistency equation of the form
Θf(Θ) = Θ, where
f(Θ) ≡ 1〈k〉
n∑
k=1
λδk2P (k)
γ(δ + µ) + λ(δ + γ)kΘ+ αγ(δ + µ)Θ2
. (2.4)
Since f ′(Θ) < 0 and f(1) < 1, the equation Θf(Θ) = Θ has a unique non-trivial solution if
and only if f(0) > 1, that is
λδ〈k2〉
γ(δ + µ)〈k〉 > 1, (2.5)
where 〈k2〉 =∑nk=1 k2P (k). These analyses lead to the following result.
Lemma 2.2. Define the epidemic threshold
R0 :=
λδ〈k2〉
γ(δ + µ)〈k〉 .
If R0 > 1, then system (2.2) admits a unique positive equilibrium E
∗(S∗1 , I
∗
1 , . . . , S
∗
n, I
∗
n),
which corresponds to the endemic equilibrium of system (1.3) and satisfies

S∗k =
γδ + αδγ(Θ∗)2
γ(δ + µ) + λ(δ + γ)kΘ∗ + αγ(δ + µ)(Θ∗)2
,
I∗k =
λδkΘ∗
γ(δ + µ) + λ(δ + γ)kΘ∗ + αγ(δ + µ)(Θ∗)2
, k = 1, 2, . . . , n.
(2.6)
where Θ∗ = 〈k〉−1∑nk=1 kP (k)I∗k ∈ (0, 1) is the unique positive root of the equation
Θ =
1
〈k〉
n∑
k=1
λδk2P (k)Θ
γ(δ + µ) + λ(δ + γ)kΘ+ αγ(δ + µ)Θ2
.
Remark 2.1. From Lemma 2.2, we can see that the epidemic threshold is determined in
terms of the network structure and this threshold is same as that derived in Ref. [2]. In
other words, the nonlinear incidence rate does not affect the threshold R0. Besides, as the
result obtained in Ref. [14], the spreading processes of our model do not possess an epidemic
threshold in an infinite scale-free network since 〈k2〉 → ∞ in this situation.
53 Global stability analysis
In this section, we investigate the globally asymptotical stability of the disease-free equilib-
rium E0 as well as the endemic equilibrium E∗.
Theorem 3.1. Let R0 :=
λδ〈k2〉
γ(δ+µ)〈k〉
< 1. Then the disease-free equilibrium E0 = ( δ
δ+µ
, 0, . . . , δ
δ+µ
, 0)
of system (2.2) is globally asymptotically stable, i.e., the disease fades out.
Proof. We first claim that
lim sup
t→+∞
Sk(t) =
δ
δ + µ
:= S0k . (3.1)
Since by Lemma 2.1, we have 0 < Sk(t), Ik(t) < 1, and 0 < Θ(t) < 1 for all t > 0. From the
first equation of system (2.2), it follows that
dSk(t)
dt
≤ δ − (δ + µ)Sk(t). (3.2)
which implies (3.1). So for any ǫ > 0, there holds Sk(t) ≤ δδ+µ + ǫ = S0k + ǫ when t is
sufficiently large. Thus from the second equation of system (2.2), we have
dIk(t)
dt
< λk(S0k + ǫ)Θ(t)− γIk(t). (3.3)
It then suffices to show the positive solutions of the system
dIk(t)
dt
= λk(S0k + ǫ)Θ(t)− γIk(t) (3.4)
tend to zero at t goes to infinity. Consider the Lyapunov function
V (t) =
n∑
k=1
wkIk(t), (3.5)
where
wk =
kP (k)
γ〈k〉 , k = 1, 2, . . . , n.
Calclulating the derivative of V (t) along the positive solutions of (3.4), we have
dV (t)
dt
=
n∑
k=1
wk[λk(S
0
k + ǫ)Θ(t)− γIk(t)],
=
n∑
k=1
kP (k)
γ〈k〉 [λk(S
0
k + ǫ)Θ(t)− γIk(t)],
= Θ(t)
(
R0 +
λ〈k2〉ǫ
γ〈k〉 − 1
)
.
(3.6)
Since R0 < 1, we can fix an ǫ > 0 small enough such that R0 +
λ〈k2〉ǫ
γ〈k〉
< 1. That ensures
dV
dt
≤ 0 and dV
dt
= 0 holds only if Ik = 0 for k = 1, · · · , n. Hence the trivial solution of (3.4)
is globally asymptotically stable. Further from the nonnegativeness of the positive solution
of (2.2) and the the comparison theorem, we complete the proof.
6Now our task is to claim the globally asymptotical stability of the endemic equilibrium.
Theorem 3.2. Let R0 :=
λδ〈k2〉
γ(δ+µ)〈k〉
> 1. If α ≥ αc := λ
2n2(R0)2
16ω2
or α ≤ αl := 2ωλn with constant
ω > 0 defined in equation (B.5), then the endemic equilibrium E∗(S∗1 , I
∗
1 , . . . , S
∗
n, I
∗
n) of system
(2.2) is globally asymptotically stable.
Proof. By Lemma 2.1, we have 0 < Sk(t) < 1, 0 < Θ(t) < 1 for all t > 0. The first equation
of (2.2) can be reformulated as
S ′k(t) = δ − (δ + µ)Sk(t)− δIk(t)− λkSk(t)
Θ(t)
1 + αΘ2(t)
. (3.7)
Moreover, one can derive from the second equation of (2.2) that
Θ′(t) =
1
〈k〉
n∑
k=1
kP (k)I ′k(t)
=
1
〈k〉
n∑
k=1
kP (k)
[
λkSk(t)
Θ(t)
1 + αΘ2(t)
− γIk(t)
]
= −γΘ(t) + λ〈k〉
n∑
k=1
k2P (k)Sk(t)
Θ(t)
1 + αΘ2(t)
.
(3.8)
Consider the following Lyapunov function
V (t) =
1
2
n∑
k=1
{
ak
(
Sk(t)− S∗k
)2
+mak(Rk(t)−R∗k)2
}
+Θ(t)−Θ∗ −Θ∗ ln Θ(t)
Θ∗
,
where
R∗k = 1− S∗k − I∗k , ak =
kP (k)
〈k〉S∗k
, k = 1, 2, · · · , n,
and the positive constant m will be determined later.
Calculating the derivative of V (t) along the positive solution of (2.2), we have
V ′ =
n∑
k=1
ak(Sk − S∗k)S ′k +
n∑
k=1
mak(Rk −R∗k)R′k +
Θ−Θ∗
Θ
Θ′ =: V1 + V2 + V3. (3.9)
Using (3.8) and the identity 1 = λ
γ〈k〉
n∑
k=1
k2P (k)S∗
k
1+α(Θ∗)2
, we obtain
V3 =γ(Θ−Θ∗)
(
−1 + λ
γ〈k〉
n∑
k=1
k2P (k)Sk
1 + αΘ2
)
=(Θ−Θ∗) λ〈k〉
n∑
k=1
k2P (k)
(
Sk
1 + αΘ2
− S
∗
k
1 + α(Θ∗)2
)
=
λ
〈k〉
n∑
k=1
k2P (k)
[
(Sk − S∗k)(Θ−Θ∗)
1 + α(Θ∗)2
− αSk(Θ−Θ
∗)(Θ2 − (Θ∗)2)
(1 + α(Θ∗)2)(1 + αΘ2)
]
.
(3.10)
7Using the last equation of (1.3) and the identity γI∗k − δR∗k + µS∗k = 0, we have
V2 =
n∑
k=1
mak(Rk − R∗k) (γIk − δRk + µSk)
=
n∑
k=1
mak(Rk − R∗k)
[
γ(Ik − I∗k)− δ(Rk − R∗k) + µ(Sk − S∗k)
]
=
n∑
k=1
mak(Rk − R∗k)
[− γ(Rk −R∗k)− γ(Sk − S∗k)− δ(Rk − R∗k) + µ(Sk − S∗k)]
= −
n∑
k=1
(γ + δ)mak(Rk − R∗k)2 −
n∑
k=1
(γ − µ)mak(Rk −R∗k)(Sk − S∗k).
(3.11)
Using (3.7) and the identity δ = (δ + µ)S∗k + δI
∗
k + λkS
∗
k
Θ∗
1+α(Θ∗)2
, we have
V1 =
n∑
k=1
ak(Sk − S∗k)
(
δ − (δ + µ)Sk − δIk − λkSk Θ
1 + αΘ2
)
=
n∑
k=1
ak(Sk − S∗k)
{
−(δ + µ)(Sk − S∗k)− δ(Ik − I∗k) + λk
[
S∗kΘ
∗
1 + α(Θ∗)2
− SkΘ
1 + αΘ2
]}
=
n∑
k=1
ak(Sk − S∗k)
{
−µ(Sk − S∗k) + δ(Rk −R∗k) + λk
[
S∗kΘ
∗
1 + α(Θ∗)2
− SkΘ
1 + αΘ2
]}
=−
n∑
k=1
µak(Sk − S∗k)2 +
n∑
k=1
δak(Sk − S∗k)(Rk − R∗k)
− Θ
1 + αΘ2
n∑
k=1
λkak(Sk − S∗k)2 −
n∑
k=1
λkakS
∗
k
1 + α(Θ∗)2
(Sk − S∗k)(Θ−Θ∗)
+
n∑
k=1
αλkakS
∗
k(Sk − S∗k)
Θ(Θ2 − (Θ∗)2)
(1 + α(Θ∗)2)(1 + αΘ2)
.
(3.12)
Note that the final term of right hand side of the above equality can be written as
n∑
k=1
αλkakS
∗
k(Sk − S∗k)
Θ(Θ2 − (Θ∗)2)
(1 + α(Θ∗)2)(1 + αΘ2)
=
n∑
k=1
αλkakS
∗
k(Sk − S∗k)
[
(Θ−Θ∗)(Θ2 − (Θ∗)2)
(1 + α(Θ∗)2)(1 + αΘ2)
+
Θ∗(Θ2 − (Θ∗)2)
(1 + α(Θ∗)2)(1 + αΘ2)
]
=
n∑
k=1
αλkakS
∗
kSk
(Θ−Θ∗)(Θ2 − (Θ∗)2)
(1 + α(Θ∗)2)(1 + αΘ2)
−
n∑
k=1
αλkak(S
∗
k)
2(Θ + Θ∗)
(1 + α(Θ∗)2)(1 + αΘ2)
(Θ−Θ∗)2
+
n∑
k=1
αλkakS
∗
kΘ
∗(Θ + Θ∗)
(1 + α(Θ∗)2)(1 + αΘ2)
(Sk − S∗k)(Θ−Θ∗).
8Substituting it into (3.12) yields
V1 =−
n∑
k=1
µak(Sk − S∗k)2 +
n∑
k=1
δak(Sk − S∗k)(Rk − R∗k)
− Θ
1 + αΘ2
n∑
k=1
λkak(Sk − S∗k)2
+
n∑
k=1
αλkakS
∗
kΘ
∗(Θ + Θ∗)
(1 + α(Θ∗)2)(1 + αΘ2)
(Sk − S∗k)(Θ−Θ∗)
−
n∑
k=1
αλkak(S
∗
k)
2(Θ + Θ∗)
(1 + α(Θ∗)2)(1 + αΘ2)
(Θ−Θ∗)2
−
n∑
k=1
λkakS
∗
k
[
(Sk − S∗k)(Θ−Θ∗)
1 + α(Θ∗)2
− αSk(Θ−Θ
∗)(Θ2 − (Θ∗)2)
(1 + α(Θ∗)2)(1 + αΘ2)
]
.
(3.13)
Since ak =
kP (k)
〈k〉S∗
k
, we find the final term of (3.13) is equal to −V3. Then combining (3.11), it
follows that
V ′ =−
n∑
k=1
akFk(m)− Θ
1 + αΘ2
n∑
k=1
λkak(Sk − S∗k)2
+
n∑
k=1
αλkakS
∗
kΘ
∗(Θ + Θ∗)
(1 + α(Θ∗)2)(1 + αΘ2)
(Sk − S∗k)(Θ−Θ∗)
−
n∑
k=1
αλkak(S
∗
k)
2(Θ + Θ∗)
(1 + α(Θ∗)2)(1 + αΘ2)
(Θ−Θ∗)2,
(3.14)
where
Fk(m) := µ(Sk − S∗k)2 +
[
(γ − µ)m− δ](Rk −R∗k)(Sk − S∗k) + (γ + δ)m(Rk − R∗k)2. (3.15)
In the Appendix B, we show there exists m∗ > 0 such that
Fk(m
∗) ≥ ω(m∗)(Sk − S∗k)2 + ν(m∗)(Rk − R∗k)2, (3.16)
where ω(m∗), ν(m∗) > 0 are two constants shown in (B.5) and (B.6). For simplicity, in the
following, we denote ω(m∗) by ω, ν(m∗) by ν respectively.
9Substituting (3.16) into (3.14), we have
V ′ ≤−
n∑
k=1
ωak(Sk − S∗k)2 −
n∑
k=1
νak(Rk − R∗k)2 −
Θ
1 + αΘ2
n∑
k=1
λkak(Sk − S∗k)2
+
n∑
k=1
αλkakS
∗
kΘ
∗(Θ + Θ∗)
(1 + α(Θ∗)2)(1 + αΘ2)
(Sk − S∗k)(Θ−Θ∗)
−
n∑
k=1
αλkak(S
∗
k)
2(Θ + Θ∗)
(1 + α(Θ∗)2)(1 + αΘ2)
(Θ−Θ∗)2
=− Θ
1 + αΘ2
n∑
k=1
λkak(Sk − S∗k)2 −
n∑
k=1
νak(Rk − R∗k)2
−
n∑
k=1
ωak
{
X2k −
αλkS∗kΘ
∗(Θ + Θ∗)
ω(1 + α(Θ∗)2)(1 + αΘ2)
XkY +
αλk(S∗k)
2(Θ + Θ∗)
ω(1 + α(Θ∗)2)(1 + αΘ2)
Y 2
}
,
(3.17)
where
Xk = Sk − S∗k , Y = Θ−Θ∗. (3.18)
Below we prove that
X2k −
αλkS∗kΘ
∗(Θ + Θ∗)
ω(1 + α(Θ∗)2)(1 + αΘ2)
XkY +
αλk(S∗k)
2(Θ + Θ∗)
ω(1 + α(Θ∗)2)(1 + αΘ2)
Y 2 ≥ 0. (3.19)
For this purpose, it suffices to show the following
∆ :=
[
αλkS∗kΘ
∗(Θ + Θ∗)
ω(1 + α(Θ∗)2)(1 + αΘ2)
]2
− 4 αλk(S
∗
k)
2(Θ + Θ∗)
ω(1 + α(Θ∗)2)(1 + αΘ2)
=
αλk(S∗k)
2(Θ + Θ∗)
ω(1 + α(Θ∗)2)(1 + αΘ2)
[
αλk(Θ∗)2(Θ + Θ∗)
ω(1 + α(Θ∗)2)(1 + αΘ2)
− 4
]
≤ 0.
(3.20)
Notice that 0 ≤ Θ,Θ∗ ≤ 1. Then when α ≤ 2ω
nλ
, obviously we have
αλk(Θ∗)2(Θ + Θ∗)
ω(1 + α(Θ∗)2)(1 + αΘ2)
− 4 ≤ 2αλn
ω
− 4 ≤ 0, (3.21)
which implies (3.20).
On the other hand, by the inequalities a2 + b2 ≥ 1
2
(a+ b)2 and a2 + b2 ≥ 2ab, we have
(1 + α(Θ∗)2)(1 + αΘ2) =1 + α
[
Θ2 + (Θ∗)2
]
+ α2Θ2(Θ∗)2
≥1 + α[Θ2 + (Θ∗)2]
≥1 + α
2
(Θ + Θ∗)2,
(3.22)
10
and
I∗k ≤
λδkΘ∗
γ(δ + µ)(1 + α(Θ∗)2)
≤ λδk
2
√
αγ(δ + µ)
, k = 1, 2, · · · , n. (3.23)
It follows from (3.23) that
Θ∗ =〈k〉−1
n∑
k=1
kP (k)I∗k ≤
λδ
2
√
αγ(δ + µ)〈k〉
n∑
k=1
k2P (k) =
R0
2
√
α
. (3.24)
Substituting (3.22) and (3.24) into (3.20) and using the assumption α ≥ λ2n2(R0)2
16ω2
, we obtain
αλk(Θ∗)2(Θ + Θ∗)
ω(1 + α(Θ∗)2)(1 + αΘ2)
− 4 ≤ λk(Θ
∗)2
ω
2
(Θ + Θ∗)
− 4
≤2λkΘ
∗
ω
− 4
≤λnR0
ω
√
α
− 4 ≤ 0,
which implies (3.20). Thus (3.19) holds when α ≥ αc or α ≤ αl, so it follows from (3.17)
that
dV
dt
≤− Θ
1 + αΘ2
n∑
k=1
λkak(Sk − S∗k)2 −
n∑
k=1
νδak(Rk −R∗k)2 ≤ 0. (3.25)
Also dV
dt
= 0 if and only if Sk = S
∗
k and Rk = R
∗
k for k = 1, 2 · · · , n. According to the
LaSalle’s invariant principle [5], (S∗1 , R
∗
1, . . . , S
∗
n, R
∗
n) is globally asymptotically stable, so is
(S∗1 , I
∗
1 , . . . , S
∗
n, I
∗
n). The proof is completed.
Remark 3.1. From Theorem 3.2, we can see under the condition R0 > 1, the endemic
equilibrium is globally asymptotically stable if α ≥ αc or α ≤ al. In the section of numerical
experiment, we find that it seems that in the case of R0 > 1, for any α > 0 the system (2.2)
is globally attractive. Also it is worth noting when α = 0, the proposed system (1.3) can
be seen as a generalization to the model proposed in Chen and Sun [3]. The global stability
of the endemic equilibrium is proved under no assumptions on the vaccination percentage µ
and the recovered rate γ, which improves the results obtained in [3]. Although the parameter
α > 0 does not affect the epidemic threshold, we can show easily that
lim sup
t→∞
Ik(t) <
λk
2γ
√
α
, (3.26)
which together with equation (3.23), we can see that a larger α can accelerate the extinction of
the disease and reduce the level of disease, which is further verified in the numerical results.
4 Numerical results
In this section, we will give some numerical simulations to illustrate the theoretical findings.
Our simulations are based on the BA network with maximum degree n = 500. The degree
distribution P (k) = ck−m , and the constant c satisfying
∑n
k=1 P (k) = 1.
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Figure 1: The time series of infected nodes in (2.2) with R0 < 1.
In all of the experiments below, we fix m = 3, λ = 0.01 and δ = 0.02. In Fig.1, we choose
γ = 0.01 and µ = 0.2. By simple computations, we can derive R0 ≈ 0.3759 < 1. The time
series of infected nodes with degree k = 100, 200, · · · , 500 are shown in Fig.1(a)(α = 0.1) and
Fig.1(b)(α = 10). The initial values are Sk(0) = 0.3, Ik(0) = 0.1, Rk(0) = 0.6 for any degree
k. It can be seen that the disease eventually becomes extinct when R0 < 1, which implies
that the disease-free equilibrium is stable. Meanwhile it should be noted that, although for
both choices of α > 0, the density of the infected node with a bigger degree experiences a
peak before it leads to the disease-free equilibrium, the larger α is, the lower the peak level
is, which means that large α can effectively degrade the epidemic peak when it breaks out
initially. To show the global stability of the disease-free equilibrium, we choose 10 different
initial values to plot the time series of I400(t) in Fig.2. Obviously all trajectories converge
to the trivial equilibrium and this supports the global stability of disease-free equilibrium.
Also as is shown in Fig.2(b), when R0 < 1, the larger α > 0 is , the faster the disease dies
out.
In Fig.3 and Fig.4, we choose µ = 0.02 and γ = 0.01. Obviously we have µ > γ. By
simple computations, we can derive R0 ≈ 2.0673 > 1. Using the equation (B.5), we obtain
ω = 0.0040. Thus we have αl = 0.0016 and αc = 417349.00. We choose α = 10
−3 and 106
respectively so that the condition α < αl or α > αc in Theorem 3.2 is satisfied. In Fig.5
and Fig.6, we choose µ = 0.001 and γ = 0.01. Thus we have µ < γ and R0 ≈ 3.9377 > 1.
Accordingly, the parameters in Theorem 3.2 are computed as ω = 0.0004, αl = 0.0002, αc ≈
1.3 × 108. So in this case we choose α = 10−4 < αl and α = 109 > αc respectively. As
can be see from Fig.3 and Fig.5, in the case of R0 > 1 the disease will persist on a positive
steady level. Fig.4 and Fig.6 display the evolutions of I400(t) for a set of initial conditions.
In both cases, as can be seen from Fig.3 to Fig.6, the endemic equilibrium E∗ is globally
asymptotically stable whenever R0 > 1 and α > αc or α < αl, which is in agreement with
Theorem 3.2. Again we can see in Fig.3 and Fig.5, when the disease is endemic, the densities
of the infected nodes decreases as α increases, which means that a larger α can accelerate
the extinction of the disease and reduce the level of disease.
When R0 > 1, Theorem 3.2 shows the endemic equilibrium E
∗ is globally asymptotically
stable when α is sufficiently large or small enough. However, as is shown in Fig.7, for any
12
0 10 20 30 40 50 60 70 80 90 100
0
0.2
0.4
0.6
0.8
1
Time t
I
4
0
0
(t
)
(a) α = 0.1
0 10 20 30 40 50 60 70 80 90 100
0
0.2
0.4
0.6
0.8
1
Time t
I
4
0
0
(t
)
(b) α = 10
Figure 2: The time series of I400(t) with 10 different initial values and R0 < 1.
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Figure 3: The time series of infected nodes in (2.2) with R0 > 1 and µ > γ.
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Figure 4: The time series of I400(t) with 10 different initial values when R0 > 1 and µ > γ.
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Figure 5: The time series of infected nodes in (2.2) with R0 > 1 and µ < γ.
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Figure 6: The time series of I400(t) with 10 different initial values when R0 > 1 and µ < γ.
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Figure 7: The time series of infected nodes in (2.2) with R0 > 1 and α = 10.
α > 0 it seems that E∗ is indeed attractive when R0 > 1. However, the rigourous proof to
this conclusion is still mathematically difficult which will be considered later.
5 Conclusion
In this paper, we have discussed an SIRS epidemic model with vaccination and nonomontone
incidence rate on complex networks. The nonlinear incidence rate can be used to interpret
the psychological effect, namely, the incidence rate would decrease at high infective levels due
to the quarantine of infected individuals or the protection measures taken by the susceptible
ones. Although the parameter α does not affect the epidemic threshold, it plays a role in
weakening the spreading of disease, as can be seen in equations (3.23) and (3.26). We have
shown by Lyapunov function that without additional conditions on the constants µ and γ,
the endemic equilibrium of system (1.3) is globally asymptotically stable, thus the disease
becomes endemic. The results can be viewed as an important supplement to the result in [3].
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Furthermore, numerical simulations are done. As has been seen, the simulations verify the
globally asymptotical stability of E∗ and controlling effect of the inhibitory factor α > 0 on
reducing the disease level.
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Appendix A Proof of Lemma 2.1
Since Sk(0) > 0 for k = 1, 2, · · · , n, by continuity, we have that for any k, there exists some
tk > 0 such that Sk(t) > 0 for any t ∈ (0, tk). Thus, the set Ek := {τ > 0;Sk(t)) > 0, ∀t ∈
(0, τ)} is not empty for any k = 1, 2, · · · , n. Let αk = sup Ek for k = 1, 2, · · · , n. Then
αk > 0 for k = 1, 2, · · · , n.
We will show Sk(t) > 0 for all t > 0 and all k = 1, 2, · · · , n. To prove this, it suffices to
show that αk = ∞ for k = 1, 2, · · · , n. Suppose, on the contrary, that αm < ∞ for some
m ∈ {1, 2, · · · , n}. Then Sm(t) > 0 for all t ∈ (0, αm). By continuity, there must have
Sm(αm) = 0. In the following, we will show this is not true.
Firstly, we will prove Θ(t) > 0 for all t > 0. From the second equation of (2.2), we have
dΘ(t)
dt
=
[
λ
〈k〉
n∑
k=1
k2P (k)
Sk(t)
1 + αΘ2(t)
− γ
]
Θ(t) =: X(t)Θ(t), (A.1)
which gives
Θ(t) = Θ(0) exp
{∫ t
0
X(s)ds
}
> 0, ∀t > 0.
Thus, for any t ∈ (0, αm), by the second equation of (2.2), we also obtain that
d
dt
(exp{γt}Im(t)) = λmSm(t) Θ(t)
1 + αΘ2(t)
exp{γt} > 0, (A.2)
which means that Im(t) ≥ 0 for all t ∈ (0, αm].
Next we will prove that Sm(t) + Im(t) < 1 for all t ∈ (0, αm]. Adding the two equations
in (2.2) yields
d(Sk + Ik)
dt
= δ − (δ + µ)(Sk + Ik) + (µ− γ)Ik, k = 1, 2, · · · , n, (A.3)
which is equivalent to
d(Sk + Ik)
dt
= δ − (δ + γ)(Sk + Ik) + (γ − µ)Ik, k = 1, 2, · · · , n. (A.4)
If µ ≤ γ, we derive from (A.3) with k = m that
d(Sm + Im)
dt
≤δ − (δ + µ)(Sm + Im)
<(δ + µ)(1− Sm − Im), ∀t ∈ (0, αm].
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This implies that d
dt
(exp{(δ + µ)t}(1− Sm(t)− Im(t))) > 0 for all t ∈ (0, αm], which to-
gether with Sm(0)+ Im(0) ≤ 1 yields that Sm+ Im < 1 on (0, αm]. While if µ > γ, we derive
from (A.4) that
d(Sm + Im)
dt
≤δ − (δ + γ)(Sm + Im)
<(δ + γ)(1− Sm − Im), ∀t ∈ (0, αm].
This gives that d
dt
(exp{(δ + γ)t}(1− Sm − Im)) > 0 on (0, αm], which also implies that
Sm + Im < 1 on (0, αm].
Thus, it follows from the first equation of (2.2) that
d
dt
(
exp
{∫ t
0
(
µ+ λm
Θ(s)
1 + αΘ2(s)
)
ds
}
Sm(t)
) ∣∣∣∣
t=αm
= δ(1− Sm(αm)− Im(αm)) exp
{∫ αm
0
(
µ+ λm
Θ(s)
1 + αΘ2(s)
)
ds
}
> 0,
which means Sm(t) < Sm(αm) = 0 for t ∈ (αm − ǫ, αm) ⊂ (0, αm), where ǫ is an arbitrarily
positive constant. This is apparently a contradiction. Thus we have αk = ∞ for k =
1, 2, · · · , n. In conclusion, we have Sk(t) > 0 for all t > 0.
Then in the same way, we get Ik(t) > 0 from the second equation of (2.2) and Sk(t) +
Ik(t) < 1 from (A.3) and (A.4) for all t > 0. Summing up the above arguments and combining
the fact Sk(t) + Ik(t) + Rk(t) = 1, we have 0 < Sk(t), Ik(t), Rk(t) < 1 and 0 < Θ(t) < 1 for
all t > 0 and all k = 1, 2, · · · , n. This completes the proof.
Appendix B Proof of equation (3.16)
Denote X = Rk − R∗k and Y = Sk − S∗k . Then following the expression of Fk(m) in (3.15),
we have
Fk(m) = (γ + δ)mX
2 + [(γ − µ)m− δ]XY + µY 2
= (γ + δ)m
[
X +
(γ − µ)m− δ
2(γ + δ)m
Y
]2
+ 2ω(m)Y 2
= µ
[
Y +
(γ − µ)m− δ
2µ
X
]2
+ 2ν(m)X2,
(B.1)
where ω(m) = − △(m)
8(γ+δ)m
and ν(m) = −△(m)
8µ
with
△(m) = [(γ − µ)m− δ]2 − 4µ(γ + δ)m
= (γ − µ)2m2 − [2δ(γ − µ) + 4µ(γ + δ)]m+ δ2. (B.2)
We now show there exists m∗ > 0 such that △(m∗) < 0. We prove this by two parts.
1. If µ = γ, we can choose m∗ = δ
4µ
> 0. It is easy to see △(m∗) = −γδ < 0.
2. If µ 6= γ, let m∗ = δγ+µδ+2µγ
(γ−µ)2
> 0, obviously we have
△(m∗) = −4µγ(γ + δ)(δ + µ)
(γ − µ)2 < 0. (B.3)
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Thus the above claim is proved. So we have ω(m∗) > 0 and ν(m∗) > 0, from which we
have
Fk(m
∗) ≥ ω(m∗)(Sk − S∗k)2 + ν(m∗)(Rk − R∗k)2, (B.4)
with
ω(m∗) = − △(m
∗)
8(γ + δ)m∗
, (B.5)
and
ν(m∗) = −△(m
∗)
8µ
. (B.6)
References
[1] S. Bansal, B. T. Grenfell, and L. A. Meyers. When individual behaviour matters: ho-
mogeneous and network models in epidemiology. Journal of the Royal Society Interface,
4(16):879–891, 2007.
[2] H. Chen and J. Sun. Global stability of delay multigroup epidemic models with
group mixing and nonlinear incidence rates. Applied Mathematics and Computation,
218(8):4391–4400, 2011.
[3] L. Chen and J. Sun. Global stability and optimal control of an sirs epidemic model on
heterogeneous networks. Physica A: Statistical Mechanics and its Applications, 410:196–
204, 2014.
[4] S. Huang, F. Chen, and L. Chen. Global dynamics of a network-based siqrs epidemic
model with demographics and vaccination. Communications in Nonlinear Science and
Numerical Simulation, 43:296–310, 2017.
[5] J. LaSalle. The Stability of Dynamical Systems. SIAM, Philadelphia, PA, 1976.
[6] C.-H. Li. Dynamics of a network-based sis epidemic model with nonmonotone incidence
rate. Physica A: Statistical Mechanics and its Applications, 427:234–243, 2015.
[7] C.-H. Li, C.-C. Tsai, and S.-Y. Yang. Analysis of epidemic spreading of an sirs model in
complex heterogeneous networks. Communications in Nonlinear Science and Numerical
Simulation, 19(4):1042–1054, 2014.
[8] T. Li, Y. Wang, and Z.-H. Guan. Spreading dynamics of a siqrs epidemic model on
scale-free networks. Communications in Nonlinear Science and Numerical Simulation,
19(3):686–692, 2014.
[9] J. Liu and T. Zhang. Epidemic spreading of an seirs model in scale-free networks. Com-
munications in Nonlinear Science and Numerical Simulation, 16(8):3375–3384, 2011.
[10] M. Liu and J. Run. Modelling the spread of sexually transmitted diseases on scale-free
networks. Chinese Physics B, 18(6):2115–2120, 2009.
[11] Y. Moreno, R. Pastor-Satorras, and A. Vespignani. Epidemic outbreaks in complex
heterogeneous networks. European Physical Journal B, 26(4):521–529, 2002.
18
[12] Y. Muroya, Y. Enatsu, and Y. Nakata. Global stability of a delayed SIRS epidemic
model with a non-monotonic incidence rate. Journal of Mathematical Analysis and
Applications, 377(1):1–14, 2011.
[13] M. Newman. Spread of epidemic disease on networks. Physical Review E - Statistical
Physics, Plasmas, Fluids, and Related Interdisciplinary Topics, 66(1), 2002.
[14] R. Pastor-Satorras and A. Vespignani. Epidemic spreading in scale-free networks. Phys-
ical Review Letters, 86(14):3200–3203, 2001.
[15] R. Pastor-Satorras and A. Vespignani. Epidemic dynamics in finite size scale-free net-
works. Physical Review E - Statistical Physics, Plasmas, Fluids, and Related Interdis-
ciplinary Topics, 65(3), 2002.
[16] X. Peng, X. Xu, X. Fu, and T. Zhou. Vaccination intervention on epidemic dynamics
in networks. Physical Review E, 87(2):022813, 2013.
[17] L. Wang and G.-Z. Dai. Global stability of virus spreading in complex heterogeneous
networks. SIAM Journal on Applied Mathematics, 68(5):1495–1502, 2008.
[18] Y. Wang, Z. Jin, Z. Yang, Z.-K. Zhang, T. Zhou, and G.-Q. Sun. Global analysis of
an sis model with an infective vector on complex networks. Nonlinear Analysis: Real
World Applications, 13(2):543–557, 2012.
[19] X. Wei, L. Liu, and W. Zhou. Global stability and attractivity of a network-based SIS
epidemic model with nonmonotone incidence rate. Physica A: Statistical Mechanics and
its Applications, 469:789–798, 2017.
[20] X. Wei, G. Xu, L. Liu, and W. Zhou. Global stability of endemic equilibrium of an
epidemic model with birth and death on complex networks. Physica A: Statistical
Mechanics and its Applications, 477:78–84, 2017.
[21] D. Xiao and S. Ruan. Global analysis of an epidemic model with nonmonotone incidence
rate. Mathematical Biosciences, 208(2):419–429, 2007.
[22] W. Yang, C. Sun, and J. Arino. Global analysis for a general epidemiological model with
vaccination and varying population. Journal of Mathematical Analysis and Applications,
372(1):208–223, 2010.
[23] H. Yuan, G. Liu, and G. Chen. On modeling the crowding and psychological effects
in network-virus prevalence with nonlinear epidemic model. Applied Mathematics and
Computation, 219(5):2387–2397, 2012.
[24] J. Zhang and J. Sun. Stability analysis of an sis epidemic model with feedback mech-
anism on networks. Physica A: Statistical Mechanics and its Applications, 394:24–32,
2014.
[25] G. Zhu, G. Chen, and X. Fu. Effects of active links on epidemic transmission over social
networks. Physica A: Statistical Mechanics and its Applications, 468:614 – 621, 2017.
19
[26] G. Zhu, X. Fu, and G. Chen. Global attractivity of a network-based epidemic sis
model with nonlinear infectivity. Communications in Nonlinear Science and Numerical
Simulation, 17(6):2588–2594, 2012.
